Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an announcement.
Botanix Pharmaceuticals has applied for quotation of 160,000 new fully paid ordinary shares on the Australian Securities Exchange. The shares, issued on 13 April 2026 following the exercise or conversion of existing options or other convertible securities, will modestly increase the company’s quoted capital base and may provide additional liquidity for investors.
The most recent analyst rating on (AU:BOT) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Ltd is an Australia-listed biotechnology company focused on developing pharmaceutical products. The company operates in the pharmaceuticals and life sciences industry and its securities trade on the Australian Securities Exchange under the ticker BOT.
Average Trading Volume: 15,652,456
Technical Sentiment Signal: Sell
Current Market Cap: A$94.92M
Learn more about BOT stock on TipRanks’ Stock Analysis page.